These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 34469459)

  • 1. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage.
    Abe H; Kunita A; Otake Y; Kanda T; Kaneda A; Ushiku T; Fukayama M
    PLoS One; 2021; 16(9):e0256440. PubMed ID: 34469459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
    Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
    Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC.
    Wang W; Zhang Y; Liu W; Zhang X; Xiao H; Zhao M; Luo B
    Theranostics; 2020; 10(25):11549-11561. PubMed ID: 33052232
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
    Fukayama M; Kunita A; Kaneda A
    Adv Exp Med Biol; 2018; 1045():437-457. PubMed ID: 29896679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Epstein-Barr virus and gastric cancer (review).
    Shinozaki-Ushiku A; Kunita A; Fukayama M
    Int J Oncol; 2015 Apr; 46(4):1421-34. PubMed ID: 25633561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.
    Abe H; Maeda D; Hino R; Otake Y; Isogai M; Ushiku AS; Matsusaka K; Kunita A; Ushiku T; Uozaki H; Tateishi Y; Hishima T; Iwasaki Y; Ishikawa S; Fukayama M
    Virchows Arch; 2012 Oct; 461(4):367-77. PubMed ID: 22915242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated gastric carcinoma: a newly defined entity.
    Chen JN; He D; Tang F; Shao CK
    J Clin Gastroenterol; 2012 Apr; 46(4):262-71. PubMed ID: 22392024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus is absent in gastric superficial neoplastic lesions.
    Ribeiro J; Malta M; Galaghar A; Afonso LP; Libânio D; Medeiros R; Dinis-Ribeiro M; Pimentel-Nunes P; Sousa H
    Virchows Arch; 2019 Dec; 475(6):757-762. PubMed ID: 31673776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma.
    Zhou H; Tan S; Li H; Lin X
    Mol Med Rep; 2019 Mar; 19(3):2125-2136. PubMed ID: 30747208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
    Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
    World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations.
    Abe H; Kaneda A; Fukayama M
    Pathobiology; 2015; 82(5):212-23. PubMed ID: 26337667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
    Yang J; Liu Z; Zeng B; Hu G; Gan R
    Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach.
    Fukayama M; Hayashi Y; Iwasaki Y; Chong J; Ooba T; Takizawa T; Koike M; Mizutani S; Miyaki M; Hirai K
    Lab Invest; 1994 Jul; 71(1):73-81. PubMed ID: 8041121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
    Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
    Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lost expression of AT-rich interaction domain 1A in the gastric mucosa-A constituent of field cancerization in the stomach.
    Abe H; Rokutan H; Totoki Y; Nakamura H; Shibata T; Ushiku T; Fukayama M
    Pathol Int; 2023 Jun; 73(6):234-245. PubMed ID: 37014148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.
    Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N
    J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
    Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
    Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
    Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma.
    Zhao D; Liu S; Sun L; Zhao Z; Liu S; Kuang X; Shu J; Luo B
    Virus Res; 2016 Jul; 220():52-6. PubMed ID: 27071854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.